References

Anderson, Keaven M, and Jason B Clark. 2010. “Fitting Spending Functions.” Statistics in Medicine 29 (3): 321–27.

Anderson, Keaven M, Zifang Guo, Jing Zhao, and Linda Z Sun. 2022. “A Unified Framework for Weighted Parametric Group Sequential Design.” Biometrical Journal 64 (7): 1219–39.

Armitage, Peter, CK McPherson, and BC Rowe. 1969. “Repeated Significance Tests on Accumulating Data.” Journal of the Royal Statistical Society: Series A (General) 132 (2): 235–44.

Chan, Ivan SF, and Norman R Bohidar. 1998. “Exact Power and Sample Size for Vaccine Efficacy Studies.” Communications in Statistics - Theory and Methods 27 (6): 1305–22.

Chen, YH Joshua, David L DeMets, and K K Gordon Lan. 2004. “Increasing the Sample Size When the Unblinded Interim Result Is Promising.” Statistics in Medicine 23 (7): 1023–38.

DeMets, David L, Curt D Furberg, and Lawrence M Friedman, eds. 2006. Data Monitoring in Clinical Trials: A Case Studies Approach. New York: Springer.

Farrington, Conor P, and Godfrey Manning. 1990. “Test Statistics and Sample Size Formulae for Comparative Binomial Trials with Null Hypothesis of Non-Zero Risk Difference or Non-Unity Relative Risk.” Statistics in Medicine 9 (12): 1447–54.

Fleiss, Joseph L, Alex Tytun, and Hans K Ury. 1980. “A Simple Approximation for Calculating Sample Sizes for Comparing Independent Proportions.” Biometrics 36 (2): 343–46.

Gordon, Ian, and Ray Watson. 1996. “The Myth of Continuity-Corrected Sample Size Formulae.” Biometrics 52 (1): 71–76.

Jennison, Christopher, and Bruce W Turnbull. 2000. Group Sequential Methods with Applications to Clinical Trials. Boca Raton, FL: Chapman & Hall/CRC.

Kim, Kyungmann, and Anastasios A Tsiatis. 1990. “Study Duration for Clinical Trials with Survival Response and Early Stopping Rule.” Biometrics 46 (1): 81–92.

Lachin, John M, and Mary A Foulkes. 1986. “Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-up, Noncompliance, and Stratification.” Biometrics 42 (3): 507–19.

Lan, K K Gordon, and David L DeMets. 1983. “Discrete Sequential Boundaries for Clinical Trials.” Biometrika 70 (3): 659–63.

———. 1989. “Group Sequential Procedures: Calendar Versus Information Time.” Statistics in Medicine 8 (10): 1191–98.

Lehmacher, Walter, and Gernot Wassmer. 1999. “Adaptive Sample Size Calculations in Group Sequential Trials.” Biometrics 55 (4): 1286–90.

Maurer, Willi, and Frank Bretz. 2013. “Multiple Testing in Group Sequential Trials Using Graphical Approaches.” Statistics in Biopharmaceutical Research 5 (4): 311–20.

Miettinen, Olli, and Markku Nurminen. 1985. “Comparative Analysis of Two Rates.” Statistics in Medicine 4 (2): 213–26.

Müller, Hans-Helge, and Helmut Schäfer. 2004. “A General Statistical Principle for Changing a Design Any Time During the Course of a Trial.” Statistics in Medicine 23 (16): 2497–2508.

O’Brien, Peter C, and Thomas R Fleming. 1979. “A Multiple Testing Procedure for Clinical Trials.” Biometrics 35 (3): 549–56.

Pocock, Stuart J. 1977. “Group Sequential Methods in the Design and Analysis of Clinical Trials.” Biometrika 64 (2): 191–99.

Polack, Fernando P., Stephen J. Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, et al. 2020. “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.” New England Journal of Medicine 383 (27): 2603–15.

Proschan, Michael A, K K Gordon Lan, and Janet Turk Wittes. 2006. Statistical Monitoring of Clinical Trials: A Unified Approach. New York: Springer.

Rodrigues, Josemar, Vicente G Cancho, Mário de Castro, and Francisco Louzada-Neto. 2009. “On the Unification of Long-Term Survival Models.” Statistics & Probability Letters 79 (6): 753–59.

Snedecor, George W, and William G Cochran. 1989. Statistical Methods. Eighth. Ames, IA: Iowa State University Press.

The CAPTURE Investigators. 1997. “Randomised Placebo-Controlled Trial of Abciximab Before and During Coronary Intervention in Refractory Unstable Angina: The CAPTURE Study.” The Lancet 349 (9063): 1429–35.

Whitehead, John. 1992. “Overrunning and Underrunning in Sequential Clinical Trials.” Controlled Clinical Trials 13 (2): 106–21.

Zhou, Jing, Adeniyi Adewale, Yue Shentu, Jiajun Liu, and Keaven Anderson. 2014. “Information-Based Sample Size Re-Estimation in Group Sequential Design for Longitudinal Trials.” Statistics in Medicine 33 (22): 3801–14.